Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
8 studies found for:    18946293 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Comparison of Sugammadex With Neostigmine Administered at 1-2 PTCs After Administration of Rocuronium or Vecuronium (19.4.302)(P05945)
Condition: Anesthesia, General
Interventions: Drug: sugammadex;   Drug: neostigmine
2 Completed Sugammadex Compared With Neostigmin/Atropin for Neuromuscular Block Reversal in Patients With Obstructive Sleep Apnea
Condition: Obstructive Sleep Apnea
Interventions: Drug: Sugammadex;   Drug: Neostigmine
3 Completed Sugammadex and Neostigmine at Shallow Neuromuscular Blockade
Condition: Neuromuscular Block
Intervention: Drug: Sugammadex, Neostigmine, Saline
4 Completed Sugammadex and Neostigmine at Residual Neuromuscular Blockade
Condition: Residual Neuromuscular Block (TOF-ratio of 0.2)
Interventions: Drug: Sugammadex;   Drug: Neostigmine;   Drug: Saline
5 Completed Neuromuscular Blockade Improves Surgical Conditions
Condition: Neuromuscular Blockade
Intervention: Other: Neuromuscular blockade with rocuronium and reversal with sugammadex
6 Recruiting Sugammadex/Neostigmine and Liver Transplantation
Conditions: Postoperative Residual Curarization;   Liver Transplantation
Interventions: Drug: sugammadex;   Drug: Neostigmine
7 Completed Effects of Neuromuscular Block Reversal With Sugammadex vs Neostigmine on Postoperative Respiratory Outcomes After Major Abdominal Surgery
Condition: Major Abdominal Surgery
Interventions: Drug: Neostigmine;   Drug: Sugammadex;   Drug: Atropine
8 Not yet recruiting Deep vs Moderate Block: Impact on Operating Conditions & Patient Satisfaction
Condition: Neuromuscular Blockade
Interventions: Drug: Deep neuromuscular blockade;   Drug: Moderate neuromuscular blockade

Study has passed its completion date and status has not been verified in more than two years.